Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares IssuedShares OutstandingShares Outstanding
Ratios

OptimizeRx (OPRX) Leases (2019 - 2026)

OptimizeRx's Leases history spans 7 years, with the latest figure at $404000.0 for Q4 2025.

  • On a quarterly basis, Leases rose 10.38% to $404000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $404000.0, a 10.38% increase, with the full-year FY2025 number at $404000.0, up 10.38% from a year prior.
  • Leases hit $404000.0 in Q4 2025 for OptimizeRx, down from $481000.0 in the prior quarter.
  • Over the last five years, Leases for OPRX hit a ceiling of $10.5 million in Q1 2022 and a floor of $14544.0 in Q2 2023.
  • Historically, Leases has averaged $863817.4 across 5 years, with a median of $379241.0 in 2021.
  • Biggest five-year swings in Leases: tumbled 97.98% in 2023 and later soared 3145.32% in 2024.
  • Tracing OPRX's Leases over 5 years: stood at $328820.0 in 2021, then decreased by 28.44% to $235320.0 in 2022, then soared by 143.5% to $573000.0 in 2023, then plummeted by 36.13% to $366000.0 in 2024, then rose by 10.38% to $404000.0 in 2025.
  • Business Quant data shows Leases for OPRX at $404000.0 in Q4 2025, $481000.0 in Q3 2025, and $528000.0 in Q2 2025.